A61K 51/0495
Pretargeting
Official title: {Pretargeting}
A61K51/0495 (Pretargeting) appears on 45 US grants and 99 published applications in this corpus.
Search patents in A61K- Granted patents
- 45
- Published applications
- 99
- Assignees
- 61
- Inventors
- 230
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 0 |
| 2005 | 1 | 4 |
| 2006 | 0 | 1 |
| 2007 | 1 | 2 |
| 2008 | 0 | 5 |
| 2009 | 1 | 2 |
| 2010 | 2 | 3 |
| 2011 | 0 | 2 |
| 2012 | 1 | 3 |
| 2013 | 3 | 8 |
| 2014 | 3 | 4 |
| 2015 | 2 | 3 |
| 2016 | 4 | 6 |
| 2017 | 2 | 3 |
| 2018 | 2 | 3 |
| 2019 | 2 | 3 |
| 2020 | 3 | 2 |
| 2021 | 0 | 13 |
| 2022 | 1 | 10 |
| 2023 | 4 | 6 |
| 2024 | 2 | 7 |
| 2025 | 3 | 4 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CD19 antibodies and methods of using the same28 Apr 2026US 12,612,456 B2Memorial Sloan Kettering Cancer Center
- Multimodal fluorine-CY3/5/7-DOTA-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy27 Jan 2026US 12,533,428 B2Cornell University
- Bioorthogonal compositions20 Jan 2026US 12,527,874 B2Tambo, Inc.
- Modular self assembly disassembly (SADA) technologies1 Jul 2025US 12,343,401 B2Memorial Sloan Kettering Cancer Center
- TCO conjugates and methods for delivery of therapeutic agents25 Mar 2025US 12,257,326 B2The Regents of the University of California
- Methods for reducing and/or preventing de-chelation of a chelated radioisotope24 Sep 2026US 2026/0284236 A1Curadel Surgical Innovations, Inc.
- Antibodies for chelated radionuclides15 Jan 2026US 2026/0015436 A1Hoffmann-La Roche Inc.
- Biotin orthogonal streptavidin system2 Oct 2025US 2025/0304705 A1
- Modular self assembly disassembly (sada) technologies25 Sep 2025US 2025/0295794 A1Memorial Sloan Kettering Cancer Center
- Pre-targeting17 Apr 2025US 2025/0122304 A1
Most cited
By later US patents
- System for targeted delivery of therapeutic agents127US 8,709,483 B2Massachusetts Institute of Technology · 2014
- Pretargeting kit, method and agents used therein40US 9,463,256 B2Koninklijke Philips N. V. · 2016
- System for targeted delivery of therapeutic agents36US 8,802,153 B2Massachusetts Institute of Technology · 2014
- Therapeutic using a bispecific antibody33US 6,458,933 B1Immunomedics, Inc. · 2002
- In-situ radioactive medical device31US 6,264,596 B1Meadox Medicals, Inc. · 2001